These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24420801)

  • 1. [Drug-induced liver injury with an autoimmune phenotype following anti-TNF Therapy - presentation of cases and review of literature].
    Rösner S; Schad A; Kittner J; Rahman F; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Z Gastroenterol; 2014 Jan; 52(1):58-63. PubMed ID: 24420801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.
    Ghabril M; Bonkovsky HL; Kum C; Davern T; Hayashi PH; Kleiner DE; Serrano J; Rochon J; Fontana RJ; Bonacini M;
    Clin Gastroenterol Hepatol; 2013 May; 11(5):558-564.e3. PubMed ID: 23333219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
    Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
    J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
    Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in psoriatic patients treated with anti-TNF-α therapy.
    Bardazzi F; Odorici G; Virdi A; Antonucci VA; Tengattini V; Patrizi A; Balestri R
    J Dtsch Dermatol Ges; 2014 May; 12(5):401-6. PubMed ID: 24797746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis-B reactivation during treatment with tumor necrosis factor-α blocker adalimumab in a patient with psoriasis arthritis].
    Kouba M; Rudolph SE; Hrdlicka P; Zuber MA
    Dtsch Med Wochenschr; 2012 Jan; 137(1-2):23-6. PubMed ID: 22180279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management.
    Viganò M; Degasperi E; Aghemo A; Lampertico P; Colombo M
    Expert Opin Biol Ther; 2012 Feb; 12(2):193-207. PubMed ID: 22188392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.
    Rossi RE; Parisi I; Despott EJ; Burroughs AK; O'Beirne J; Conte D; Hamilton MI; Murray CD
    World J Gastroenterol; 2014 Dec; 20(46):17352-9. PubMed ID: 25516646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review.
    Kok B; Lester ELW; Lee WM; Hanje AJ; Stravitz RT; Girgis S; Patel V; Peck JR; Esber C; Karvellas CJ;
    Dig Dis Sci; 2018 Jun; 63(6):1654-1666. PubMed ID: 29564668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miscellaneous adverse events with biologic agents (excludes infection and malignancy).
    Feuerstein JD; Cheifetz AS
    Gastroenterol Clin North Am; 2014 Sep; 43(3):543-63. PubMed ID: 25110258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship?
    Efe C
    Autoimmun Rev; 2013 Jan; 12(3):337-9. PubMed ID: 22841985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.
    Rodrigues S; Lopes S; Magro F; Cardoso H; Horta e Vale AM; Marques M; Mariz E; Bernardes M; Lopes J; Carneiro F; Macedo G
    World J Gastroenterol; 2015 Jun; 21(24):7584-8. PubMed ID: 26140007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.
    Sokolove J; Strand V; Greenberg JD; Curtis JR; Kavanaugh A; Kremer JM; Anofrei A; Reed G; Calabrese L; Hooper M; Baumgartner S; Furst DE;
    Ann Rheum Dis; 2010 Sep; 69(9):1612-7. PubMed ID: 20448284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hepatitis triggered by administration of an herbal medicine.
    Kamiyama T; Nouchi T; Kojima S; Murata N; Ikeda T; Sato C
    Am J Gastroenterol; 1997 Apr; 92(4):703-4. PubMed ID: 9128330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A; Bonnet D; Thebault S; Alric L
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
    Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.
    Guerra I; Algaba A; Pérez-Calle JL; Chaparro M; Marín-Jiménez I; García-Castellanos R; González-Lama Y; López-Sanromán A; Manceñido N; Martínez-Montiel P; Quintanilla E; Taxonera C; Villafruela M; Romero-Maté A; López-Serrano P; Gisbert JP; Bermejo F
    J Crohns Colitis; 2012 Jun; 6(5):518-23. PubMed ID: 22398059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
    Ortonne JP; Chimenti S; Reich K; Gniadecki R; Sprøgel P; Unnebrink K; Kupper H; Goldblum O; Thaçi D
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1012-20. PubMed ID: 21214631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.
    Lopetuso LR; Mocci G; Marzo M; D'Aversa F; Rapaccini GL; Guidi L; Armuzzi A; Gasbarrini A; Papa A
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.
    Iborra M; Beltrán B; Bastida G; Aguas M; Nos P
    J Crohns Colitis; 2011 Apr; 5(2):157-61. PubMed ID: 21453886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.